Via John Ellis’s outstanding News Items newsletter, the Economist declares that glp-1 drugs, such as the weight-loss wonder Ozempic, have “all the makings of one of the most successful classes of drugs in history,” capable of treating not only diabetes but also cardiovascular and kidney diseases and possibly even Alzheimer’s, addictions and, believe it or not, aging itself. … Forget it being one of the most successful drugs in history. It could be one of the most significant developments in human history, period.